Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men

Archives of Internal Medicine

Volumn 161, Issue 22, 2001, Pages 2685-2692

  Lemieux, Isabelle ^a,b   Lamarche, Benott ^b   Couillard, Charles ^a,b   Pascot, Agnès ^a,b   Cantin, Bernard ^a,b   Bergeron, Jean ^b   Dagenais, Gilles R ^a   Després, Jean Pierre ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CANADA; CHOLESTEROL BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLISM; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0035842484     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.22.2685     Document Type: Article

References (44)

1. The new thinking on lipids and coronary artery disease
2. Coronary heart disease: Reducing the risk: The scientific background to primary and secondary prevention of coronary heart disease: A worldwide view
3. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
4. The measurement of apolipoprotein B should replace the conventional lipid profile in screening for cardiovascular risk
5. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec Cardiovascular Study
6. Increased plasma plasminogen activator inhibitor 1 levels: A possible link between insulin resistance and atherothrombosis
7. Hyperinsulinemia as an independent risk factor for ischemic heart disease
8. A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue
9. Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study
10. Final report: Canadian Consensus Conference on the prevention of heart and vascular disease by altering serum cholesterol and lipoprotein risk factors
11. Second report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
12. Joint British recommendations on prevention of coronary heart disease in clinical practice
13. Recommendations for the management and treatment of dyslipidemia: Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias
14. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT
15. Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study
16. High density lipoprotein as a protective factor against coronary heart disease: The Framingham study
17. Plasma high density lipoprotein concentration and development of ischaemic heart disease
18. The emergence of triglycerides as a significant independent risk factor in coronary artery disease
19. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: Implications for treatment
20. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome
21. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
22. First coronary heart disease event rates in relation to major risk factors: Québec Cardiovascular Study
23. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study)
24. International diagnostic criteria for acute myocardial infarction and acute stroke
25. HDL-cholesterol as a marker of coronary heart disease risk: The Québec Cardiovascular Study
26. Increase in plasma high density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma
27. 2 precipitation procedures for estimating cholesterol in high-density lipoproteins
28. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
29. Electroimmunoassay
30. Plasma insulin and lipoprotein concentrations: An atherogenic association?
31. Identification of multiple subclasses of plasma low density lipoproteins in normal humans
32. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution: Results from the Framingham Offspring Study
33. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease: An 8-year follow-up in the Copenhagen Male Study
34. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease: Results from the Québec Cardiovascular Study
35. Variability of lipid measurements: Relevance for the clinician
36. Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels
37. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk
38. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease
39. Postprandial triglyceride response in visceral obesity in men
40. The dense LDL phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men
41. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapoB, small, dense LDL) in men?
42. Abdominal obesity and the metabolic syndrome
43. Abdominal obesity as important component of insulin-resistance syndrome
44. Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk